Golden has been acquired by ComplyAdvantage.Read about it here ⟶

KPI Therapeutics

KPI Therapeutics is a company that focuses on developing potentially game changing autoimmune therapies.

Overview Structured Data Issues Contributors Activity

kpitherapeutics.com

Is a

Organization

Company

Company attributes

Industry

Location

Seattle, Washington, United States

CEO

Founder

AngelList URL

angel.co/kpi-therapeutics

Investors

Founded Date

2013

Total Funding Amount (USD)

27,000

Latest Funding Type

Series A

Wellfound ID

kpi-therapeutics

Other attributes

Company Operating Status

Active

KPI Therapeutics is a company that focuses on developing potentially game changing autoimmune therapies. Its platform targets autoimmune diseases of the skin that have millions of sufferers in the US and are a multi-billion-dollar market. Its lead drug, dalazatide, has completed Phase 1 trials and demonstrated clinical activity in patients.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like KPI Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.